Novavax Announces Pricing of $150 Million Offering of Converti...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Dec. 16, 2022 /PRNewswire-Asianet/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an offering of $150 million aggregate principal amount of it...
Authors: LATEST ASIANET NEWS RELEASES